Literature DB >> 21216879

A genome-wide association study identifies novel loci associated with circulating IGF-I and IGFBP-3.

Robert C Kaplan1, Ann-Kristin Petersen, Ming-Huei Chen, Alexander Teumer, Nicole L Glazer, Angela Döring, Carolyn S P Lam, Nele Friedrich, Anne Newman, Martina Müller, Qiong Yang, Georg Homuth, Anne Cappola, Norman Klopp, Holly Smith, Florian Ernst, Bruce M Psaty, H-Erich Wichmann, Douglas B Sawyer, Reiner Biffar, Jerome I Rotter, Christian Gieger, Lisa S Sullivan, Henry Völzke, Kenneth Rice, Ariadni Spyroglou, Heyo K Kroemer, Y-D Ida Chen, Jenny Manolopoulou, Matthias Nauck, Howard D Strickler, Mark O Goodarzi, Martin Reincke, Michael N Pollak, Martin Bidlingmaier, Ramachandran S Vasan, Henri Wallaschofski.   

Abstract

Insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-3 (IGFBP-3) are involved in cell replication, proliferation, differentiation, protein synthesis, carbohydrate homeostasis and bone metabolism. Circulating IGF-I and IGFBP-3 concentrations predict anthropometric traits and risk of cancer and cardiovascular disease. In a genome-wide association study of 10 280 middle-aged and older men and women from four community-based cohort studies, we confirmed a known association of single nucleotide polymorphisms in the IGFBP3 gene region on chromosome 7p12.3 with IGFBP-3 concentrations using a significance threshold of P < 5 × 10(-8) (P = 3.3 × 10(-101)). Furthermore, the same IGFBP3 gene locus (e.g. rs11977526) that was associated with IGFBP-3 concentrations was also associated with the opposite direction of effect, with IGF-I concentration after adjustment for IGFBP-3 concentration (P = 1.9 × 10(-26)). A novel and independent locus on chromosome 7p12.3 (rs700752) had genome-wide significant associations with higher IGFBP-3 (P = 4.4 × 10(-21)) and higher IGF-I (P = 4.9 × 10(-9)) concentrations; when the two measurements were adjusted for one another, the IGF-I association was attenuated but the IGFBP-3 association was not. Two additional loci demonstrated genome-wide significant associations with IGFBP-3 concentration (rs1065656, chromosome 16p13.3, P = 1.2 × 10(-11), IGFALS, a confirmatory finding; and rs4234798, chromosome 4p16.1, P = 4.5 × 10(-10), SORCS2, a novel finding). Together, the four genome-wide significant loci explained 6.5% of the population variation in IGFBP-3 concentration. Furthermore, we observed a borderline statistically significant association between IGF-I concentration and FOXO3 (rs2153960, chromosome 6q21, P = 5.1 × 10(-7)), a locus associated with longevity. These genetic loci deserve further investigation to elucidate the biological basis for the observed associations and clarify their possible role in IGF-mediated regulation of cell growth and metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21216879      PMCID: PMC3043664          DOI: 10.1093/hmg/ddq560

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  48 in total

Review 1.  Cardiovascular function in acromegaly.

Authors:  R N Clayton
Journal:  Endocr Rev       Date:  2003-06       Impact factor: 19.871

2.  Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene.

Authors:  Horacio M Domené; Sonia V Bengolea; Alicia S Martínez; M Gabriela Ropelato; Patricia Pennisi; Paula Scaglia; Juan J Heinrich; Héctor G Jasper
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

Review 3.  Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors.

Authors:  D Le Roith
Journal:  N Engl J Med       Date:  1997-02-27       Impact factor: 91.245

4.  Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.

Authors:  A H Heald; J K Cruickshank; L K Riste; J E Cade; S Anderson; A Greenhalgh; J Sampayo; W Taylor; W Fraser; A White; J M Gibson
Journal:  Diabetologia       Date:  2001-03       Impact factor: 10.122

5.  Full genome screen for Alzheimer disease: stage II analysis.

Authors:  Amanda Myers; Fabienne Wavrant De-Vrieze; Peter Holmans; Marian Hamshere; Richard Crook; Danielle Compton; Helen Marshall; David Meyer; Shantia Shears; Jeremy Booth; Dzanan Ramic; Heather Knowles; John C Morris; Nigel Williams; Nadine Norton; Richard Abraham; Pat Kehoe; Hywel Williams; Varuni Rudrasingham; Francis Rice; Peter Giles; Nigel Tunstall; Lesley Jones; Simon Lovestone; Julie Williams; Michael J Owen; John Hardy; Alison Goate
Journal:  Am J Med Genet       Date:  2002-03-08

6.  Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD.

Authors:  Ioannis Vogiatzis; Grigoris Stratakos; Davina C M Simoes; Gerasimos Terzis; Olga Georgiadou; Charis Roussos; Spyros Zakynthinos
Journal:  Thorax       Date:  2007-06-15       Impact factor: 9.139

7.  Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study.

Authors:  Ronenn Roubenoff; Helen Parise; Hélène A Payette; Leslie W Abad; Ralph D'Agostino; Paul F Jacques; Peter W F Wilson; Charles A Dinarello; Tamara B Harris
Journal:  Am J Med       Date:  2003-10-15       Impact factor: 4.965

8.  Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study.

Authors:  Anders Juul; Thomas Scheike; Michael Davidsen; Jesper Gyllenborg; Torben Jørgensen
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

9.  SORCS1: a novel human type 2 diabetes susceptibility gene suggested by the mouse.

Authors:  Mark O Goodarzi; Donna M Lehman; Kent D Taylor; Xiuqing Guo; Jinrui Cui; Manuel J Quiñones; Susanne M Clee; Brian S Yandell; John Blangero; Willa A Hsueh; Alan D Attie; Michael P Stern; Jerome I Rotter
Journal:  Diabetes       Date:  2007-04-10       Impact factor: 9.461

Review 10.  Utility of free IGF-I measurements.

Authors:  Jan Frystyk
Journal:  Pituitary       Date:  2007       Impact factor: 3.599

View more
  37 in total

Review 1.  Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes.

Authors:  David R Clemmons
Journal:  Endocrinol Metab Clin North Am       Date:  2012-06       Impact factor: 4.741

2.  Adjusting for heritable covariates can bias effect estimates in genome-wide association studies.

Authors:  Hugues Aschard; Bjarni J Vilhjálmsson; Amit D Joshi; Alkes L Price; Peter Kraft
Journal:  Am J Hum Genet       Date:  2015-01-29       Impact factor: 11.025

3.  A robust method for genome-wide association meta-analysis with the application to circulating insulin-like growth factor I concentrations.

Authors:  Tao Wang; Baiyu Zhou; Tingwei Guo; Martin Bidlingmaier; Henri Wallaschofski; Alexander Teumer; Ramachandran S Vasan; Robert C Kaplan
Journal:  Genet Epidemiol       Date:  2013-10-25       Impact factor: 2.135

4.  Genome-wide association and functional studies identify a role for IGFBP3 in hip osteoarthritis.

Authors:  Daniel S Evans; Frederic Cailotto; Neeta Parimi; Ana M Valdes; Martha C Castaño-Betancourt; Youfang Liu; Robert C Kaplan; Martin Bidlingmaier; Ramachandran S Vasan; Alexander Teumer; Gregory J Tranah; Michael C Nevitt; Steven R Cummings; Eric S Orwoll; Elizabeth Barrett-Connor; Jordan B Renner; Joanne M Jordan; Michael Doherty; Sally A Doherty; Andre G Uitterlinden; Joyce B J van Meurs; Tim D Spector; Rik J Lories; Nancy E Lane
Journal:  Ann Rheum Dis       Date:  2014-06-13       Impact factor: 19.103

5.  Reassessing the Association between Circulating Vitamin D and IGFBP-3: Observational and Mendelian Randomization Estimates from Independent Sources.

Authors:  Vanessa Y Tan; Kalina M Biernacka; Tom Dudding; Carolina Bonilla; Rebecca Gilbert; Robert C Kaplan; Qi Qibin; Alexander Teumer; Richard M Martin; Claire M Perks; Nicholas J Timpson; Jeff M P Holly
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-08-02       Impact factor: 4.254

6.  Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).

Authors:  Konstantinos K Tsilidis; Ruth C Travis; Paul N Appleby; Naomi E Allen; Sara Lindström; Demetrius Albanes; Regina G Ziegler; Marjorie L McCullough; Afshan Siddiq; Aurelio Barricarte; Sonja I Berndt; H Bas Bueno-de-Mesquita; Stephen J Chanock; E David Crawford; W Ryan Diver; Susan M Gapstur; Edward Giovannucci; Fangyi Gu; Christopher A Haiman; Richard B Hayes; David J Hunter; Mattias Johansson; Rudolf Kaaks; Laurence N Kolonel; Peter Kraft; Loic Le Marchand; Kim Overvad; Silvia Polidoro; Elio Riboli; Fredrick R Schumacher; Victoria L Stevens; Dimitrios Trichopoulos; Jarmo Virtamo; Walter C Willett; Timothy J Key
Journal:  Int J Cancer       Date:  2013-02-15       Impact factor: 7.396

7.  Genetic determinants of uterine fibroid size in the multiethnic NIEHS uterine fibroid study.

Authors:  Brahim Aissani; Kui Zhang; Howard Wiener
Journal:  Int J Mol Epidemiol Genet       Date:  2015-09-09

8.  Assessment of age-related changes in heritability and IGF-1 gene effect on circulating IGF-1 levels.

Authors:  Liran Franco; Frances M K Williams; Svetlana Trofimov; Ida Malkin; Gabriela Surdulescu; Timothy Spector; Gregory Livshits
Journal:  Age (Dordr)       Date:  2014-02-04

9.  Circulating IGF-axis protein levels and their relation with levels of plasma adipocytokines and macronutrient consumption in women.

Authors:  Jeannette M Beasley; Nicole M Wedick; Swapnil N Rajpathak; Xiaonan Xue; Michelle D Holmes; Marc J Gunter; Judith Wylie-Rosett; Thomas E Rohan; Michael Pollak; Robert C Kaplan; Frank B Hu; Qi Sun; Howard D Strickler
Journal:  Growth Horm IGF Res       Date:  2014-05-17       Impact factor: 2.372

10.  Genetic Regulation of Female Sexual Maturation and Longevity Through Circulating IGF1.

Authors:  Rong Yuan; Daniel M Gatti; Rebecca Krier; Ethan Malay; David Schultz; Luanne L Peters; Gary A Churchill; David E Harrison; Beverly Paigen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-07-28       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.